Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data

Abstract Diagnosing Alzheimer’s disease (AD) through pathological markers is typically costly and invasive. This study aims to find a noninvasive, cost-effective method using portable electroencephalography (EEG) to detect changes in AD-related biomarkers in cerebrospinal fluid (CSF). A total of 102...

Full description

Saved in:
Bibliographic Details
Main Authors: Masahiro Hata, Yuki Miyazaki, Kohji Mori, Kenji Yoshiyama, Shoshin Akamine, Hideki Kanemoto, Shiho Gotoh, Hisaki Omori, Atsuya Hirashima, Yuto Satake, Takashi Suehiro, Shun Takahashi, Manabu Ikeda
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86449-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594799766536192
author Masahiro Hata
Yuki Miyazaki
Kohji Mori
Kenji Yoshiyama
Shoshin Akamine
Hideki Kanemoto
Shiho Gotoh
Hisaki Omori
Atsuya Hirashima
Yuto Satake
Takashi Suehiro
Shun Takahashi
Manabu Ikeda
author_facet Masahiro Hata
Yuki Miyazaki
Kohji Mori
Kenji Yoshiyama
Shoshin Akamine
Hideki Kanemoto
Shiho Gotoh
Hisaki Omori
Atsuya Hirashima
Yuto Satake
Takashi Suehiro
Shun Takahashi
Manabu Ikeda
author_sort Masahiro Hata
collection DOAJ
description Abstract Diagnosing Alzheimer’s disease (AD) through pathological markers is typically costly and invasive. This study aims to find a noninvasive, cost-effective method using portable electroencephalography (EEG) to detect changes in AD-related biomarkers in cerebrospinal fluid (CSF). A total of 102 patients, both with and without AD-related biomarker changes (amyloid beta and phosphorylated tau), were recorded using a 2-minute resting-state portable EEG. A machine-learning algorithm then analyzed the EEG data to identify these biomarker changes. The results showed that the machine learning model could distinguish patients with AD-related biomarker changes, achieving 68.1% accuracy (AUROC 0.75) for amyloid beta and 71.2% accuracy (AUROC 0.77) for phosphorylated tau, with gamma activities being key features. When excluding cases with idiopathic normal pressure hydrocephalus, accuracy improved to 74.1% (AUROC 0.80) for amyloid beta and 73.1% (AUROC 0.80) for phosphorylated tau. This study suggests that portable EEG combined with machine learning is a promising noninvasive and cost-effective tool for early AD-related pathological marker screening, which could enhance neurophysiological understanding and diagnostic accessibility.
format Article
id doaj-art-eea120ba1815471e80e5f1b3539589e5
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-eea120ba1815471e80e5f1b3539589e52025-01-19T12:22:27ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-025-86449-2Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography dataMasahiro Hata0Yuki Miyazaki1Kohji Mori2Kenji Yoshiyama3Shoshin Akamine4Hideki Kanemoto5Shiho Gotoh6Hisaki Omori7Atsuya Hirashima8Yuto Satake9Takashi Suehiro10Shun Takahashi11Manabu Ikeda12Department of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineDepartment of Psychiatry, Osaka University Graduate School of MedicineAbstract Diagnosing Alzheimer’s disease (AD) through pathological markers is typically costly and invasive. This study aims to find a noninvasive, cost-effective method using portable electroencephalography (EEG) to detect changes in AD-related biomarkers in cerebrospinal fluid (CSF). A total of 102 patients, both with and without AD-related biomarker changes (amyloid beta and phosphorylated tau), were recorded using a 2-minute resting-state portable EEG. A machine-learning algorithm then analyzed the EEG data to identify these biomarker changes. The results showed that the machine learning model could distinguish patients with AD-related biomarker changes, achieving 68.1% accuracy (AUROC 0.75) for amyloid beta and 71.2% accuracy (AUROC 0.77) for phosphorylated tau, with gamma activities being key features. When excluding cases with idiopathic normal pressure hydrocephalus, accuracy improved to 74.1% (AUROC 0.80) for amyloid beta and 73.1% (AUROC 0.80) for phosphorylated tau. This study suggests that portable EEG combined with machine learning is a promising noninvasive and cost-effective tool for early AD-related pathological marker screening, which could enhance neurophysiological understanding and diagnostic accessibility.https://doi.org/10.1038/s41598-025-86449-2DementiaEEGAlzheimer’s diseaseAmyloid betaPhosphorylated tauMachine learning
spellingShingle Masahiro Hata
Yuki Miyazaki
Kohji Mori
Kenji Yoshiyama
Shoshin Akamine
Hideki Kanemoto
Shiho Gotoh
Hisaki Omori
Atsuya Hirashima
Yuto Satake
Takashi Suehiro
Shun Takahashi
Manabu Ikeda
Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
Scientific Reports
Dementia
EEG
Alzheimer’s disease
Amyloid beta
Phosphorylated tau
Machine learning
title Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
title_full Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
title_fullStr Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
title_full_unstemmed Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
title_short Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
title_sort screening of aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
topic Dementia
EEG
Alzheimer’s disease
Amyloid beta
Phosphorylated tau
Machine learning
url https://doi.org/10.1038/s41598-025-86449-2
work_keys_str_mv AT masahirohata screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT yukimiyazaki screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT kohjimori screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT kenjiyoshiyama screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT shoshinakamine screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT hidekikanemoto screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT shihogotoh screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT hisakiomori screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT atsuyahirashima screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT yutosatake screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT takashisuehiro screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT shuntakahashi screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata
AT manabuikeda screeningofabandphosphorylatedtaustatusinthecerebrospinalfluidthroughmachinelearninganalysisofportableelectroencephalographydata